A Micro/Nano Device for Exhaled Breath Analysis
NCT02123030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 728
Last updated 2021-06-18
Summary
Use of a microfabricated silicon device to concentrate ultra trace volatile organic compounds (VOCs) in human exhaled breath for quantitative analysis of VOCs.
Conditions
- Lung Cancer
- Pulmonary Disease
Sponsors & Collaborators
-
James Graham Brown Cancer Center
collaborator OTHER -
University of Louisville
lead OTHER
Principal Investigators
-
Xiao-An Fu, PhD · James Graham Brown Cancer Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-07
- Primary Completion
- 2018-11-28
- Completion
- 2018-11-28
Countries
- United States
Study Locations
More Related Trials
-
Exhaled Breath Biomarkers in Lung Cancer
NCT01386203 ·Status: UNKNOWN
-
Detecting Lung Cancer Based on Exhaled Breath
NCT04419207 ·Status: COMPLETED
-
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy
NCT04556435 ·Status: TERMINATED
-
Assay Development for Cancer Biomarkers
NCT02874729 ·Status: UNKNOWN
-
Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response
NCT03988192 ·Status: TERMINATED ·Phase: NA
-
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
NCT06034730 ·Status: COMPLETED
-
Mass Spectral Fingerprinting in Lung Cancer
NCT02781857 ·Status: ACTIVE_NOT_RECRUITING
-
Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer
NCT06288646 ·Status: TERMINATED
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Metabolomic Analysis of Lung Cancer
NCT00263731 ·Status: COMPLETED
-
Exhaled Breath Particles in Lung Cancer
NCT05395611 ·Status: UNKNOWN
-
Lung Cancer Indicator Detection
NCT02612532 ·Status: COMPLETED ·Phase: NA
-
EB-OCT Biopsy Guidance of Lung Cancer
NCT06556680 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
NanoSpectrometer Biomarker Discovery and Confirmation Study
NCT03275688 ·Status: TERMINATED
-
Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial
NCT06593106 ·Status: RECRUITING ·Phase: NA
-
NSCLC Liquid Biopsies and Exhaled VOC
NCT06707519 ·Status: RECRUITING
-
Breathe Anew for Lung Cancer Survivorship
NCT03773380 ·Status: COMPLETED ·Phase: PHASE1
-
Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma
NCT02951897 ·Status: UNKNOWN ·Phase: NA
-
Breath Testing in Early and Late Larynx Cancer
NCT01700647 ·Status: COMPLETED
-
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
NCT06816121 ·Status: RECRUITING
-
Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer
NCT02519972 ·Status: COMPLETED ·Phase: NA
-
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
NCT00733252 ·Status: WITHDRAWN
-
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
NCT06169163 ·Status: RECRUITING
-
The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis
NCT02965300 ·Status: UNKNOWN
-
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
NCT02932332 ·Status: COMPLETED ·Phase: PHASE2